Help us: Donate
Follow us on:



Underdog Pharmaceuticals

Organization Description

Underdog Pharmaceuticals, Inc., is pursuing a mission to treat the underlying causes of age-related disease. The company develops simple and direct interventions targeting toxic forms of cholesterol, using rationally designed molecules, to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.


Michael Kope

Underdog Pharmaceuticals

Matthew O'Connor, Ph.D.

Underdog Pharmaceuticals